NCT06688669 Examining the Effects of Removable Denture Use in Patients Over 60 Years of Age
| NCT ID | NCT06688669 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul University |
| Condition | Edentulism |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-10-25 |
| Primary Completion | 2025-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2024-10-25 with a primary completion date of 2025-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients over the age of 60 who do not currently have any removable dentures but require them will be included in the study. Patients who will receive complete dentures and those who will receive partial dentures will be assessed in separate groups. Before the fabrication of the dentures, the Mini-Mental State Examination Test (MMSE), the physical normative value test (TUG), and the Oral Functional Capacity (OFC) scoring will be conducted. No intervention will be made to the treatment during the prosthetic treatment process. The same questionnaires will be administered again three weeks after the completion of the prosthetic treatments. The impact of the use of removable dentures on test results will be evaluated. Additionally, during this session, patients will complete a patient satisfaction test regarding their dentures (OHIP-14 for patients with a removable partial denture indication, and OHIP-edent for patients with a complete denture indication). Patients will be called back after three months, and all tests will be repeated. The relationship between the Mini-Mental State Examination, the TUG test, and the OFC test with patient satisfaction will be assessed and any changes in test scores related to denture use will be investigated.
Eligibility Criteria
Inclusion Criteria: * Patients over the age of 60 * No systemic condition that would prevent the fabrication of removable dentures * Need for new removable dentures for both jaws * Ability to read and understand the questions in the tests and surveys * No barriers to communication or self-expression * No significant physical disability affecting functionality * No history of cancer or surgical operation in the head and neck region * No conditions or medications that could limit test performance (e.g., Parkinson's disease) Exclusion Criteria: * Patients under the age of 60 * Patients who do not require new removable dentures * Patients whose missing teeth can be restored with fixed prosthetic restorations and who do not need removable dentures * Patients who are illiterate * Patients with systemic conditions that prevent the fabrication of removable dentures * Patients with conditions like Parkinson's disease that could restrict test performance or who use medications with side effects causing unwanted convulsions * Patients with significant balance issues, who frequently lose balance while walking * Geriatric patients with temporary or permanent memory loss * Patients with any history of cancer in the head and neck region * Patients with severe difficulty in communication and self-expression * Patients who are not willing to participate in the study
Contact & Investigator
Olcay Şakar, Prof. Dr. Clinical Professor
STUDY CHAIR
Istanbul University
Frequently Asked Questions
Who can join the NCT06688669 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Edentulism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06688669 currently recruiting?
Yes, NCT06688669 is actively recruiting participants. Contact the research team at berk.bilgen@istanbul.edu.tr for enrollment information.
Where is the NCT06688669 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06688669 clinical trial?
NCT06688669 is sponsored by Istanbul University. The principal investigator is Olcay Şakar, Prof. Dr. Clinical Professor at Istanbul University. The trial plans to enroll 40 participants.